Market Overview

Morning Market Losers


Sunesis Pharmaceuticals (NASDAQ: SNSS) shares dipped 69.88% to $2.00 as pivotal Phase 3 VALOR trial of acute myeloid leukemia treatment did not meet primary endpoint.

Alcobra (NASDAQ: ADHD) shares declined 47.55% to $7.40 following the announcement of topline results from Phase III study of MDX in adult ADHD.

Tekmira Pharmaceuticals (NASDAQ: TKMR) shares dropped 11.07% to $26.26. Leerink Swann downgraded Tekmira Pharma from Outperform to Market Perform.

EZchip Semiconductor (NASDAQ: EZCH) shares fell 10.66% to $22.09 after the company lowered its Q3 sales forecast.

BioCryst Pharmaceuticals (NASDAQ: BCRX) dropped 9.92% to $11.53.

H&R Block (NYSE: HRB) shares slipped 5.12% to $30.04 as the company announced that the regulatory approval process for the company's deal with BofI Federal Bank won't be completed this year.

Micron Technology (NASDAQ: MU) shares fell 2.59% to $33.06 after rising 0.33% over the past week.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets


Related Articles (BCRX + ADHD)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

LinkedIn Corp Shares Have Work Left To Do: A Technical Analysis

H&R Block Inc's Bank Sale Delayed Until Next Year, Shares Down 5%